Zevra Therapeutics, Inc. ZVRA Interest and other income, net
Interest and other income, net at other companies
Other financials
Where this comes from
Reported directly by Zevra Therapeutics, Inc. in its filing.
Tagged under the XBRL concept zvra:InterestAndOtherIncomeExpenseNet.
The official record: Zevra Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Zevra Therapeutics, Inc.'s interest and other income, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Zevra Therapeutics, Inc.'s interest and other income, net?
- Zevra Therapeutics, Inc. (ZVRA) reported interest and other income, net of $3.59M in Q1 2026.
- How has Zevra Therapeutics, Inc.'s interest and other income, net changed year-over-year?
- Zevra Therapeutics, Inc.'s interest and other income, net increased by 561.0% year-over-year, from $543K to $3.59M.
- What is the long-term trend for Zevra Therapeutics, Inc.'s interest and other income, net?
- Over 2 years (2023 to 2025), Zevra Therapeutics, Inc.'s interest and other income, net has grown at a 23.7% compound annual growth rate (CAGR), from $4.54M to $6.95M.
- What does interest and other income, net mean?
- This captures the net balance of interest earned on cash and cash equivalents, interest paid on debt obligations, and other miscellaneous non-operating income or expenses. It provides insight into the company's liquidity management and the net cost of its capital structure. A positive balance indicates that the company is generating meaningful returns on its cash reserves or benefiting from non-core activities.